No Data
No Data
New stock preview | Will Saime Technology's three submission tables lead the domestic ICV simulation test industry with weak discourse power?
Industry leader still has concerns.
[IPO] Beijing SiMu Technology submits a listing application to the main board of the Hong Kong Stock Exchange
Jinwu Financial News | According to the Hong Kong Stock Exchange disclosure on May 29, Beijing Saimu Technology submitted a listing application to the main board of the Hong Kong Stock Exchange, and Guangyin International is the sole sponsor. The company is a Chinese technology company focusing on simulation technology innovation. It is mainly engaged in the design and development of ICV simulation test products and provides related testing, verification and evaluation solutions. On the financial side, the company recorded revenue of 107 million yuan, 145 million yuan and 176 million yuan respectively in 2021-2023, corresponding to profit of 37.571 million, 486.86 million and 53.431 million yuan during the same period.
New stock news | Saimu Technology submits its prospectus to the Hong Kong Stock Exchange for the third time, the largest player in the industry for ICV testing, verification, and evaluation solutions in China.
According to the disclosure on May 29th by Hong Kong Stock Exchange, Peking Saimu Technology Co., Ltd. (referred to as Saimu Technology) submitted an application to the main board of Hong Kong Stock Exchange, and Guan Yin International is its exclusive sponsor.
Caimu Technology, a simulation testing service provider for intelligent connected vehicles in which Huawei has participated, submitted a prospectus to be listed in Hong Kong
On October 31, 2023, Beijing Saimo Technology Co., Ltd. (“Saimu Technology” for short) once again submitted a prospectus on the Hong Kong Stock Exchange to issue H shares for listing on the Hong Kong Main Board. This is another application after its submission expired on December 30, 2022.
IPO News | Simu Technology submitted a second submission to the Hong Kong Stock Exchange to focus on ICV simulation testing products
According to Frost & Sullivan, in terms of revenue in 2022, the company is the second largest market participant in the ICV testing, verification and evaluation solutions industry in China.
No Data